R&D Supply chain resilience in pharma: Delivering consistency am... In an interconnected economy, industries operating on an international scale are increasingly vulnerable to supply chain disruption.
News Grail plans filings for cancer blood test after new trial Grail is eyeing FDA approval of its Galleri cancer screening blood test after a second positive phase 3 trial.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face